Morphogenesis of type II lissencephaly: Neuropathology, genetics and pathomechanisms

Neuroembryology

Volumn 2, Issue 1, 2003, Pages 32-39

  Stoltenburg Didinger, Gisela ^a,c   Steinbrecher, Alice ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Lissencephaly; Neuronal migration; O mannosyl transferase; Walker Warburg syndrome

Indexed keywords

AGYRIA; BRAIN DEVELOPMENT; BRAIN DISEASE; CONGENITAL MALFORMATION; DISEASE CLASSIFICATION; EYE DISEASE; FETUS; FETUS DEVELOPMENT; GENETIC DISORDER; HUMAN; MORPHOGENESIS; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; WALKER WARBURG SYNDROME;

EID: 0344011109     PISSN: 14248522     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068500     Document Type: Short Survey

References (49)

1. Owen R: On the Anatomy of Vertebrates. London, Longmans and Green, 1868, vol 3:Mammals.
2. Dambska M, Wisniewski K, Sher JH: Lissencephaly: Two distinct clinico-pathological types. Brain Dev 1983;5:302-310.
3. Dobyns WB, Stratton RF, Greenberg F: Syndromes with lissencephaly. I. Miller-Dieker and Norman-Roberts syndrome and isolated lissencephaly. Am J Med Genet 1984;18:509-516.
4. Dobyns WB, Kirkpatrick J, Hittner HM, Roberts RM, Kretzer FL: Syndromes with lissencephaly. II. Walker-Warburg and cerebro-oculo-muscular syndromes and a new syndrome with type II lissencephaly. Am J Med Genet 1985;22:157-195.
5. Chan WY, Kostovic I, Takashima S, Feldhaus C, Stoltenburg-Didinger G, Verney C, Yew D, Ulfig N: Normal and abnormal development of the human cerebral cortex. Neuroembryology 2002;2:78-90.
6. Uher BF, Golden JA: Neuronal migration defects of the cerebral cortex: A destination debacle. Clin Genet 2000;58:16-24.
7. Dambska M: Disturbances of cortical development. Neuropathol Pol 1993;31:105-114.
8. Squier MV: Fetal type II lissencephaly: A case report. Childs Nerv Syst 1993;9:400-402.
9. Squier MV: Development of the cortical dysplasia of type II lissencephaly. Neuropathol Appl Neurobiol 1993;19:209-213.
10. Friede R: Developmental Neuropathology, ed 2. Berlin, Springer, 1989.
11. Dobyns WB, Truwit CL: Lissencephaly and other malformations of cortical development: 1995 update. Neuropediatrics 1995;26:132-147.
12. Fukuyama Y, Kawazura M, Haruna H: A peculiar form of congenital progressive muscular dystrophy. Report of fifteen cases. Pediatria Universitatis Tokyo 1960;4:5-8.
13. Fukuyama Y, Osawa M, Suzuki H: Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev 1981;3:1-29.
14. Santavuori P, Somer H, Sainio K, Rapola J, Kruus S, Nikitin T, Ketonen L, Leisti J: Muscle-eye-brain disease. Brain Dev 1989;11:147-153.
15. Dobyns WB, Pagon RA, Armstrong D, Curry CJ, Greenberg F, Grix A, Holmes LB, Laxova R, Michels VV, Robinow M, Zimmerman RL: Diagnostic criteria for Walker-Warburg-syndrome. Am J Med Genet 1989;32:195-210.
16. Walker AE: Lissencephaly. Arch Neurol 1942;48:13-29.
17. Cormand B, Pihko H, Bayés M, Valanne L, Santavuori P, Talim B, Gershoni-Baruch R, Ahmad A, van Bokhoven H, Brunner HG, Voit T, Topaloglu H, Dobyns WB, Lehesjoki AE: Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 2001;56:1059-1069.
18. Warburg M: Hydrocephaly, congenital retinal nonattachment, and congenital falciform fold. Am J Ophthalmol 1978;85:88-94.
19. Toda T, Segawa M, Nomura Y, Nonaka I, Masuda K, Ishihara T, Sakai M, Tomita I, Origuchi Y: Localisation of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet 1993;5:283-286.
20. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, Segawa M, Yoshioka M, Saito K, Osawa M, Hamano K, Sakakihara Y, Nonaka I, Nakagone Y, Kanazawa I, Nakamura Y, Tokunaga K, Toda K: An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998;394:388-392.
21. Cormand B, Avela K, Pihko H, Santavuori P, Talim B, Topaloglu H, de la Chapelle A, Lehesjoki AE: Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage-analysis and homozygosity mapping. Am J Hum Genet 1999;64:126-135.
22. Yoshida A, Kobayashi K, Manya H, Tanigushi K, Kano H, Mizuno M, Inazu T, Mitsuhashi H, Takahashi S, Takeushi M, Herrmann R, Straub V, Talim B, Voit T, Topaloglu H, Toda T, Endo T: Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001;1:717-724.
23. Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K: Selective deficiency of alpha dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 2001;57:115-121.
24. Kano H, Kobayashi K, Herrmann R, Tachikawa M, Manya H, Nishino I, Nonaka I, Straub V, Talim B, Voit T, Topaloglu H, Endo T, Yoshikawa H, Toda T: Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun 2002;291:1283-1286.
25. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP: Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 2002;418:417-422.
26. Beltrán-Valero de Bernabé D, Currier S, Steinbrecher A, Celli J, van Beusekom E, van der Zwaag B, Kayserili H, Merlini L, Chitayat D, Dobyns WB, Cormand B, Lehesjoki AE, Cruces J, Voit T, Walsh CA, van Bokhoven H, Brunner HG: Mutations in the O-mannosyl-transferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002;71:1033-1043.
27. Leyten QH, Renkawek K, Renier WO, Gabreels FJ, Mooy CM, Ter Laak HJ, Mullaart RA: Neuropathological findings in muscle-eye-brain disease (MEB-D). Neuropathological delineation of MEB-D from congenital muscular dystrophy of the Fukuyama type. Acta Neuropathol (Berl) 1991;83:55-60.
28. Haltia M, Leivo L, Somer K, Pihko H, Paetau A, Kivela T, Tarkkanen A, Tomé F, Engvall E, Santavuori P: Muscle-eye-brain disease: A neuropathological study. Ann Neurol 1997;41:173-180.
29. Takada K, Nakamura H, Tanaka J: Cortical dysplasia in congenital muscular dystrophy with central nervous system involvement. J Neuropathol Exp Neurol 1984;43:395-407.
30. Nakano I, Funahashi M, Takada K, Toda T: Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? Pathological study of the cerebral cortex of an FCMD fetus. Acta Neuropathol (Berl) 1996;91:313-321.
31. Saito Y, Murayama S, Kawi M, Nakano I: Breached cerebral glia limitans-basal lamina complex in Fukuyama-type congenital muscular dystrophy. Acta Neuropathol (Berl) 1999;98:330-336.
32. Williams RS, Swisher CN, Jennings M, Ambler M, Caviness VS: Cerebro-ocular dysgenesis (Walker-Warburg syndrome). Neuropathology and etiologic analysis. Neurology 1984;34:1531-1541.
33. Takada K, Nakamura H, Suzumori K: Cortical dysplasia in a 23-week old fetus with Fukuyama congenital muscular dystrophy (FCMD). Acta Neuropathol (Berl) 1987;74:300-306.
34. Miller G, Ladda RL, Towfighi J: Cerebro-ocular dysplasia-muscular dystrophy (Walker-Warburg) syndrome. Findings in 20-week-old fetus. Acta Neuropathol (Berl) 1991;82:234-238.
35. Bornemann A, Aigner T, Kirchner T: Spatial and temporal development of the gliovascular tissue in type II lissencephaly. Acta Neuropathol (Berl) 1997;93:173-177.
36. Gelot A, Billette de Villemeur T, Bordarier C, Ruchoux MM, Moraine C, Ponsot G: Developmental aspects of type II lissencephaly. Comparative study of dysplastic lesions in fetal and post-natal brains. Acta Neuropathol (Berl) 1995;89:72-84.
37. Stoltenburg-Didinger G, Steinbrecher A: Brain malformation in Walker-Warburg syndrome. Acta Neuropathol (Berl) 2002;104:571.
38. Larroche JC, Nessmann C: Focal cerebral anomalies and retinal dysplasia in a 23-24-week-old-fetus. Brain Dev 1993;15:51-56.
39. Hartmann D, De Strooper B, Saftig P: Presenil-in-1 deficiency leads to loss of Cajal-Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly. Curr Biol 1999;9:719-727.
40. Hartmann D, Ziegenhagen MW, Sievers J: Meningeal cells stimulate neuronal migration and the formation of radial glial fascicles from the cerebellar external granular layer. Neurosci Lett 1998;244:129-132.
41. Sievers J, Pehlemann FW, Gude S, Berry M: Meningeal cells organize the superficial glia limitans of the cerebellum and produce components of both the interstitial matrix and the basement membrane. J Neurocytol 1994;23:135-149.
42. Halfter W, Dong S, Yip YP, Willem M, Mayer U: A critical function of the pial basement membrane in cortical histogenesis. J Neurosci 2002;22:6029-6040.
43. Georges-Labouesse E, Mark M, Messaddeq N, Gansmuller A: Essential role of alpha 6 integrins in cortical and retinal lamination. Curr Biol 1998;8:983-986.
44. Andressen C, Arnhold S, Puschmann M, Bloch W, Hescheler J, Fassler R, Addicks K: Beta 1 integrin deficiency impairs migration and differentiation of mouse embryonic stem cell derived neurons. Neurosci Lett 1998;251:165-168.
45. Graus-Porta D, Blaess S, Senften M, Littlewood-Evans A, Damsky C, Huang Z, Prban P, Klein R, Schittny J, Mueller U: Beta 1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 2001;31:1-20.
46. Choy KW, Baum L, Lam DCL, Pang CP: Molecular genetic control of retinal development. Neuroembryology 2002;1:54-60.
47. Anton ES, Kreidberg JA, Rakic P: Distinct functions of alpha 3 and alpha v integrin receptors in neuronal migration and laminar organisation of the cerebral cortex. Neuron 1999;22:277-289.
48. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP: Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 2002;418:422-425.
49. Grewal PK, Holzfeind PJ, Bittner RE, Hewitt JE: Mutant glycosyltransferase and altered glycosylation of alpha dystroglycan in the myodystrophy mouse. Nat Genet 2001;28:151-154.